AKT1 and in situ carcinoma: Moreover, the expression of p-Akt also decreased in the CIS group compared with that of in the control group (Figure 6d,e, p < 0.001), after treatment with Xiaoyaosan or rosiglitazone, the reduction was reversed (p < 0.001 and p < 0.05).